CatalystPit

PMVPPMV Pharmaceuticals, Inc.

NASDAQ · Pharmaceutical Preparations
Last close $1.67 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$89.27M
RECENT INSIDER TRADES
  • 2025-10-27 · ORBIMED ADVISORS LLC (10% Owner) · SELL
  • 2025-09-12 · ORBIMED ADVISORS LLC (10% Owner) · SELL
  • 2025-07-03 · Jalota Deepika (Chief Development Officer) · SELL
  • 2025-07-03 · Carulli Michael (Chief Financial Officer) · SELL
  • 2025-07-03 · Mack David Henry (President and CEO) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders68
Shares held38,531,310
Value$48.65M
Percent of shares outstanding72.08%
As of quarter end2026-06-30
RECENT NEWS
  • PMV Pharmaceuticals: Restoring Mutant P53 Could Create A Mispriced Cancer Opportunity
  • PMV Pharma rezafapt nears pivotal test at H.C. Wainwright
  • PMV Pharmaceuticals, Inc. · 8-K (1.01,8.01,9.01)
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
PMV Pharmaceuticals, Inc. (PMVP) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit